(株)リボミックの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4591/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2017/09/01 | 日証協 | 269,200株 | -2.92% | 33,900株 | -52.52% | 337,408株 | -0.88% | 2,600株 | -57.38% |
| 2017/08/25 | 日証協 | 277,300株 | +12.27% | 71,400株 | +475.81% | 340,408株 | +0.44% | 6,100株 | -1.61% |
| 2017/08/18 | 日証協 | 247,000株 | +3.61% | 12,400株 | +69.86% | 338,908株 | +2.05% | 6,200株 | +16.98% |
| 2017/08/10 | 日証協 | 238,400株 | +1.1% | 7,300株 | -61.98% | 332,108株 | +0.76% | 5,300株 | -36.98% |
| 2017/08/04 | 日証協 | 235,800株 | +1.59% | 19,200株 | +93.94% | 329,608株 | +0.61% | 8,410株 | +546.92% |
| 2017/07/28 | 日証協 | 232,100株 | 0% | 9,900株 | +83.33% | 327,598株 | +0.96% | 1,300株 | -77.19% |
| 2017/07/21 | 日証協 | 232,100株 | +2.29% | 5,400株 | +170% | 324,498株 | +0.68% | 5,700株 | +66.42% |
| 2017/07/14 | 日証協 | 226,900株 | +1.43% | 2,000株 | -69.7% | 322,298株 | +1.33% | 3,425株 | -31.64% |
| 2017/07/07 | 日証協 | 223,700株 | +1.73% | 6,600株 | -13.16% | 318,073株 | +0.35% | 5,010株 | +78.93% |
| 2017/06/30 | 日証協 | 219,900株 | -5.58% | 7,600株 | -50% | 316,948株 | -2.59% | 2,800株 | -18.49% |
| 2017/06/23 | 日証協 | 232,900株 | -3.44% | 15,200株 | -58.58% | 325,363株 | -1.47% | 3,435株 | -89.2% |
| 2017/06/16 | 日証協 | 241,200株 | +11.25% | 36,700株 | +1735% | 330,228株 | +8.72% | 31,800株 | +488.89% |
| 2017/06/09 | 日証協 | 216,800株 | +2.31% | 2,000株 | -77.01% | 303,728株 | +2.02% | 5,400株 | -8.47% |
| 2017/06/02 | 日証協 | 211,900株 | -3.68% | 8,700株 | -36.96% | 297,728株 | -1.59% | 5,900株 | 0% |
| 2017/05/26 | 日証協 | 220,000株 | +2.85% | 13,800株 | -28.87% | 302,528株 | +1.61% | 5,900株 | -60.71% |
| 2017/05/19 | 日証協 | 213,900株 | +4.29% | 19,400株 | +823.81% | 297,728株 | +2.55% | 15,015株 | +212.81% |
| 2017/05/12 | 日証協 | 205,100株 | -0.77% | 2,100株 | 0% | 290,313株 | -0.79% | 4,800株 | -22.58% |
| 2017/05/02 | 日証協 | 206,700株 | -1.9% | 0株 | -100% | 292,613株 | +1.32% | 6,200株 | -58.39% |
| 2017/04/28 | 日証協 | 210,700株 | +12.92% | 29,200株 | +102.78% | 288,813株 | +3.59% | 14,900株 | +170.91% |
※株式分割は考慮していませんのでご注意ください。
Page Top